Dermaseptin-Based Antiviral Peptides to Prevent COVID-19 through In Silico Molecular Docking Studies against SARS-CoV-2 Spike Protein
A pandemic coronavirus disease of 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has now been declared a global pandemic by the World Health Organization. The search for new drugs, especially by utilizing antiviral peptides is a very potential area. Through th...
Saved in:
Main Author: | Taufik Muhammad Fakih (Author) |
---|---|
Format: | Book |
Published: |
Universitas Indonesia,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potential antiviral peptides targeting the SARS-CoV-2 spike protein
by: Ibrahim Khater, et al.
Published: (2022) -
Analysis of SARS-CoV-2 Spike Protein as The Key Target in the Development of Antiviral Candidates for COVID-19 through Computational Study
by: Taufik Muhammad Fakih, et al.
Published: (2021) -
Spike protein of SARS-CoV-2 Omicron variant: An in-silico study evaluating spike interactions and immune evasion
by: Jose A. Jimenez Ruiz, et al.
Published: (2022) -
Development of SARS-CoV-2 Inhibitors Using Molecular Docking Study with Different Coronavirus Spike Protein and ACE2
by: Israa Mohamed Shamkh, et al.
Published: (2021) -
Molecular Docking and Dynamics Simulation of Several Flavonoids Predict Cyanidin as an Effective Drug Candidate against SARS-CoV-2 Spike Protein
by: Asmita Shrestha, et al.
Published: (2022)